RRL.sin.cPPT.SFFV/Ace2.IRES-puro.WPRE (MT126) Citations (12)
Originally described in: SARS-CoV-2 triggers an MDA-5-dependent interferon response which is unable to control replication in lung epithelial cells.Rebendenne A, Valadao ALC, Tauziet M, Maarifi G, Bonaventure B, McKellar J, Planes R, Nisole S, Arnaud-Arnould M, Moncorge O, Goujon C J Virol. 2021 Jan 29. pii: JVI.02415-20. doi: 10.1128/JVI.02415-20. PubMed Journal
Articles Citing RRL.sin.cPPT.SFFV/Ace2.IRES-puro.WPRE (MT126)
| Articles |
|---|
SARS-CoV-2 triggers an MDA-5-dependent interferon response which is unable to control replication in lung epithelial cells.
Rebendenne A, Valadao ALC, Tauziet M, Maarifi G, Bonaventure B, McKellar J, Planes R, Nisole S, Arnaud-Arnould M, Moncorge O, Goujon C.
J Virol. 2021 Jan 29. pii: JVI.02415-20. doi: 10.1128/JVI.02415-20.
PubMed
Associated Plasmids |
| Coincident rapid expansion of two SARS-CoV-2 lineages with enhanced infectivity in Nigeria. Ozer EA, Simons LM, Adewumi OM, Fowotade AA, Omoruyi EC, Adeniji JA, Dean TJ, Zayas J, Bhimalli PP, Ash MK, Godzik A, Schneider JR, Mamede JI, Taiwo BO, Hultquist JF, Lorenzo-Redondo R. medRxiv. 2021 Jul 2. doi: 10.1101/2021.04.09.21255206. PubMed |
| A Bioluminescent 3CL(Pro) Activity Assay to Monitor SARS-CoV-2 Replication and Identify Inhibitors. Mathieu C, Touret F, Jacquemin C, Janin YL, Nougairede A, Brailly M, Mazelier M, Decimo D, Vasseur V, Hans A, Valle-Casuso JC, de Lamballerie X, Horvat B, Andre P, Si-Tahar M, Lotteau V, Vidalain PO. Viruses. 2021 Sep 12;13(9). pii: v13091814. doi: 10.3390/v13091814. PubMed |
| Multiple expansions of globally uncommon SARS-CoV-2 lineages in Nigeria. Ozer EA, Simons LM, Adewumi OM, Fowotade AA, Omoruyi EC, Adeniji JA, Olayinka OA, Dean TJ, Zayas J, Bhimalli PP, Ash MK, Maiga AI, Somboro AM, Maiga M, Godzik A, Schneider JR, Mamede JI, Taiwo BO, Hultquist JF, Lorenzo-Redondo R. Nat Commun. 2022 Feb 3;13(1):688. doi: 10.1038/s41467-022-28317-5. PubMed |
| CD169-mediated restrictive SARS-CoV-2 infection of macrophages induces pro-inflammatory responses. Jalloh S, Olejnik J, Berrigan J, Nisa A, Suder EL, Akiyama H, Lei M, Tyagi S, Bushkin Y, Muhlberger E, Gummuluru S. bioRxiv. 2022 Mar 30. doi: 10.1101/2022.03.29.486190. PubMed |
| De novo emergence of SARS-CoV-2 spike mutations in immunosuppressed patients. Simons LM, Ozer EA, Gambut S, Dean TJ, Zhang L, Bhimalli P, Schneider JR, Mamede JI, Ison MG, Karmali R, Gordon LI, Lorenzo-Redondo R, Hultquist JF. Transpl Infect Dis. 2022 Dec;24(6):e13914. doi: 10.1111/tid.13914. Epub 2022 Aug 1. PubMed |
| Identification of potent inhibitors of SARS-CoV-2 infection by combined pharmacological evaluation and cellular network prioritization. Patten JJ, Keiser PT, Morselli-Gysi D, Menichetti G, Mori H, Donahue CJ, Gan X, Valle ID, Geoghegan-Barek K, Anantpadma M, Boytz R, Berrigan JL, Stubbs SH, Ayazika T, O'Leary C, Jalloh S, Wagner F, Ayehunie S, Elledge SJ, Anderson D, Loscalzo J, Zitnik M, Gummuluru S, Namchuk MN, Barabasi AL, Davey RA. iScience. 2022 Sep 16;25(9):104925. doi: 10.1016/j.isci.2022.104925. Epub 2022 Aug 13. PubMed |
| Preclinical assessment and randomized Phase I study of CT-P63, a broadly neutralizing antibody targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Seo JM, Kang B, Song R, Noh H, Kim C, Kim JI, Kim M, Ryu DK, Lee MH, Yang JS, Kim KC, Lee JY, Lee H, Woo HM, Kim JW, Choi JA, Song M, Tomaszewska-Kiecana M, Wolowik A, Kulesza A, Kim S, Ahn K, Jung N, Lee SY. Emerg Microbes Infect. 2022 Dec;11(1):2315-2325. doi: 10.1080/22221751.2022.2117094. PubMed |
| The SARS-CoV-2 S1 Spike Protein Promotes MAPK and NF-kB Activation in Human Lung Cells and Inflammatory Cytokine Production in Human Lung and Intestinal Epithelial Cells. Forsyth CB, Zhang L, Bhushan A, Swanson B, Zhang L, Mamede JI, Voigt RM, Shaikh M, Engen PA, Keshavarzian A. Microorganisms. 2022 Oct 10;10(10):1996. doi: 10.3390/microorganisms10101996. PubMed |
| Bulk IgG glycosylation predicts COVID-19 severity and vaccine antibody response. Ash MK, Bhimalli PP, Cho BK, Mattamana BB, Gambut S, Tarhoni I, Fhied CL, Reyes AF, Welninski SJ, Arivalagan J, Negrao F, Goel R, Beck TL, Hope TJ, Sha BE, Goo YA, Al-Harthi L, Mamede JI, Borgia JA, Kelleher NL, Schneider JR. Cell Rep. 2022 Dec 13;41(11):111799. doi: 10.1016/j.celrep.2022.111799. Epub 2022 Nov 22. PubMed |
| Anthracyclines inhibit SARS-CoV-2 infection. Wang Z, Pan Q, Ma L, Zhao J, McIntosh F, Liu Z, Ding S, Lin R, Cen S, Finzi A, Liang C. Virus Res. 2023 Sep;334:199164. doi: 10.1016/j.virusres.2023.199164. Epub 2023 Jun 28. PubMed |
| The Equal Neutralizing Effectiveness of BNT162b2, ChAdOx1 nCoV-19, and Sputnik V Vaccines in the Palestinian Population. Damour A, Faure M, Landrein N, Ragues J, Ardah N, Dhaidel H, Lafon ME, Wodrich H, Basha W. Vaccines (Basel). 2024 May 3;12(5):493. doi: 10.3390/vaccines12050493. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.